Circadian Rhythms, Clock Genes, and Their Close Relationship With Hemostasis and Fibrinolysis {#S1}
=============================================================================================

The temporal organization of a living being is influenced by environmental stimuli and by internal biological clocks that are endogenously regulated in all living things. From an evolutionary point of view, events such as day and night, represented by light/dark cycles, were incorporated as a relevant time mark to predict environmental changes and as an anticipatory mechanism to perform and optimize activity/rest cycles ([@B41]). Circadian rhythms are intrinsic biological oscillations with a period close to 24 h; in mammals, they are driven by the circadian synchronization system ([@B1]). This system has a hierarchical organization; it is composed of the pacemaker or central clock, located in the suprachiasmatic nucleus, which is synchronized through the environmental light signals that proceed from the retina and are transported by the retinohypothalamic tract ([@B21]). The central clock, in turn, synchronizes peripheral clocks located in virtually all tissues and organs through nerve and/or endocrine signals ([@B61]). Circadian rhythms are generated at cell level through transcriptional/translational loops (central and accessories loop). Interconnected and self-regulated by positive and negative feedback, these loops are composed for transcription factors collectively referred to as clock genes ([@B41]). The central loop is composed of the CLOCK:BMAL1 heterodimer, which promotes the rhythmic expression of the repressor proteins PER1-3 and CRY1-2 through E-box sites. Subsequently, PER and CRY translocate to the nucleus once they have been modified post-translationally, feeding back and limiting their own expression by displacing the CLOCK:BMAL1 from their promoter site. A cycle of this negative and positive feedback lasts approximately 24 h, thus generating circadian rhythmicity ([@B12]; [@B69]).

The CLOCK:BMAL1 also promotes rhythmic transcription of the accessory loop components, such as the REV-ERBα/β nuclear receptor, which represses the transcription of the *Bmal1* gene by binding to the retinoid-related orphan receptor response element (RORE) in the promoter site of *Bmal1* ([@B49]; [@B26]). Other genes that structure the accessory loop are retinoid-related orphan receptors (RORs); *Ror*α/β/γ have been shown to activate the transcription of *Bmal1* through the binding of their respective proteins to RORE sites ([@B22]). In addition, RORs modulate the expression of important components of the central loop such as CLOCK and CRY ([@B73]; [@B70]), which indicates that they are strongly involved in the regulation of the expression of clock genes and therefore of molecular machinery functions ([@B38]). The clock genes of the central and accessory loop regulate the rhythmic expression of other target genes called clock-controlled genes (CCGs), which in turn are related to multiple physiological functions such as behavior, metabolism, hemostasis, and immunity ([@B31]; [@B27]; [@B63]; [@B37]). The central loop is also regulated by another accessory pathway, which includes the D-box albumin transcriptional activator binding protein (DBP), transcriptionally regulated through an E-box site, and the binding protein NFIL3, transcriptionally regulated through a RORE site. The DBP and NFIL3 proteins regulate positively and negatively, respectively the expression of genes that have D-box sites at their promoter site, such as *Per*, *Cry*, or *Rev-Erb* and other CCGs ([@B73]; [@B12]; [@B34]; [@B37]). Other data indicate that the mechanisms by which CLOCK:BMAL1 regulates the transcription of core clock genes do not apply to CCGs and suggest that the primary function of CLOCK:BMAL1 is to regulate the chromatin landscape at its enhancers to facilitate the binding of other transcription factors. This implies that CCG expression would be indirect, based on the interaction between the circadian clock and other signaling pathways ([@B72]; [@B6]).

The circadian clock literally affects all physiological functions and behaviors, contributing significantly to the production and maintenance of endocrine rhythms modulating the levels of endocrine factors as well as the ability of the tissues to respond to these stimuli throughout the day ([@B55]; [@B19]; [@B9]). The evidence suggests that specific clock genes regulate different functions of the physiology of innate and adaptive immune cells ([@B64]; [@B8]; [@B53]; [@B60]), indicating that the regulation of immune response is under circadian control. Furthermore, the overall evidence shows that there is a mutual relationship: The clock controls some crucial metabolic pathways, and the metabolism feeds back to the clock machinery, synchronizing functions such as the production and expenditure of energy with the circadian patterns of the expression of metabolic genes in synchrony with the light/dark cycles, replenishing the proteins and enzymes during the resting phase that are needed to perform physiological functions in optimal conditions during the activity phase ([@B5]; [@B39]; [@B35]). Moreover, circadian rhythms are important regulators of cardiovascular physiology; peripheral clocks are present in each of the types of cardiovascular cells, regulating various physiological functions such as endothelial function, blood pressure, and heart rate ([@B11]). In relation to hemostasis, robust circadian oscillations in the number of circulating platelets and in the markers of platelet-endothelial aggregation and adhesion have been demonstrated ([@B58]). A clear circadian expression of prothrombotic factors such as von Willebrand factor has also been shown, displaying maximum expression during the activity phase in humans and rodents, while on the other hand demonstrating a clear regulation of fibrinogen expression through clock genes ([@B65]). Also, parameters of the coagulation system, such as prothrombin time (PT) and activated partial thromboplastin time (APTT), displayed a circadian rhythm, with the shortest PT being recorded late at night and early in the morning ([@B7]). All the expression profiles of circadian hemostasis previously described favor a prothrombotic phenotype when the circadian function of the molecular clock is deregulated.

Practically all tissues and organs have peripheral clocks, synchronized by powerful environmental signals such as light/dark cycles. Nowadays, modern society is further exposed to interruption of the synchrony of circadian rhythms through activities such as shift work, work at night, or chronic jet-lag, promoting a chronodisruption that has proven consequences for human health ([@B17], [@B18]). Therefore, it is not surprising to see that alterations in the circadian rhythm are involved in an increasing number of various chronic diseases, such as diabetes, obesity, chronic respiratory diseases, cardiovascular diseases (CVDs), and cancer ([@B23]; [@B57]; [@B51]; [@B66]; [@B52]). Interestingly, in several of these chronic diseases, the deregulation of the fibrinolytic system is also demonstrated in some of its components ([@B40]; [@B45]; [@B20]; [@B15]; [@B67]). In particular, an association between CVDs and an alteration in the levels of tissue plasminogen activator (tPA) expression and mainly plasminogen activator inhibitor-1 (PAI-1) has been demonstrated, the latter being studied as a possible marker of cardiovascular risk ([@B13]; [@B71]; [@B29]) and senescence ([@B16]; [@B78]; [@B74]).

Fibrinolytic Activity and Its Regulation Through Clock Genes {#S2}
============================================================

Thus far, we know that tPA and PAI-1 plasma levels oscillate robustly in circadian form in humans and rodents, decreasing and increasing, respectively, during the activity phase in both species, contributing to a state of hypofibrinolysis during this period ([@B3]; [@B2]; [@B44]; [@B59]; [@B7]). This feature allows rodent models to be used for investigating the mechanisms that regulate fibrinolysis and its possible damage (see [Figure 1](#F1){ref-type="fig"}). The rise in plasma PAI-1 levels during the beginning of the activity phase could explain the higher incidence of myocardial infarctions and strokes in humans in the morning ([@B50]). Experimental animal and cell models have shown that the expression of the *Pai-1* gene is directly regulated by clock proteins, which act as transcription factors either by stimulating or repressing its expression. In cell models, it has been shown that both heterodimers -- CLOCK/BMAL1 and CLOCK/BMAL2 -- promote the expression of the *Pai-1* gene through two E-box elements, located at its promoter site ([@B33]; [@B62]; [@B48]). Moreover, CLOCK seems to be a positive regulator for the expression of the *Pai-1* mRNA because it has been found to decrease its expression levels and have no circadian rhythm when the *Clock* gene has been silenced by a small interfering RNA (siRNA) in endothelial cell culture and in mice ([@B10]). The same occurs in a mutant mouse model for CLOCK ([@B43]) or when PER2 is overexpressed ([@B46]). Regulation through other clock genes such as CRY1/2 has shown that they act as negative regulators in the expression of the *Pai-1* mRNA and also determine the characteristic plasma oscillatory pattern of PAI-1, because an increased and arrhythmic plasmatic expression have been observed in CRY1/CRY2^--/--^ mice (N. [@B43]). In addition, the *Pai-1* transcript is promoted by RORα and repressed by REV-ERBα by binding to response elements related to the orphan receptor (RORE sites) at its promoter site ([@B76]). These clock genes (through their proteins RORα and REV-ERBα) regulate the expression of CLOCK:BMAL1 and other CCGs ([@B41]; [@B12]; [@B69]). In fact, the evidence described above demonstrates that *Pai-1* is a CCG (see [Figure 2](#F2){ref-type="fig"}). There are other important transcriptional regulations, such as the sirtuins (SIRTs), which modulate the expression of various clock genes in a circadian manner, repressing transcription through their histone deacetylase (HDAC) activity and counteracting the CLOCK histone acetylase (HAT) protein activity, which in turn promotes the expression of clock genes and CCGs ([@B5]), thus balancing the transcriptional activity of the circadian system. There is also evidence to suggest that *Pai-1* may be epigenetically modified through a mechanism that involves SIRT1, a class III chromatin histone deacetylase (SIRTUIN1), promoting heterochromatin formation and *Pai-1* gene silencing, specifically by direct acetylation of histone 4 lysine 16 (H4K16) at its promoter site ([@B32]; [@B75]).

![Oscillations in the circulating levels of PAI-1 are directed by an endogenous circadian synchronization system. **(A)** Circadian rhythm of PAI-1 in humans. An increase in circulating levels is observed leaving the resting phase (nocturnal), showing a maximum amplitude entering the activity phase (diurnal) during the first hours of the morning. **(B)** Circadian rhythm of PAI-1 in rodents. An increase in circulating levels is observed leaving the resting phase (diurnal), showing a maximum amplitude in the activity phase (nocturnal). Similarity is noted in the oscillation profile of circulating PAI-1 in the phase of activity/rest of both species; thus, a rodent model is useful for the study of key components of the fibrinolytic system.](fphys-11-00129-g001){#F1}

![The current regulatory mechanism proposed for the expression of PAI-1 as a CCG. The expression of the *Pai-1* gene is positively regulated by the CLOCK/BMAL1 dimer that binds to E-box elements and by RORα that binds to RORE sites in its promoter site. Expression is repressed by displacing the CLOCK/BMAL1 dimer by PER/CRY and by REV-ERBα, which competes with RORα for the RORE sites in the PAI-1 promoter.](fphys-11-00129-g002){#F2}

Discussion {#S3}
==========

Disturbance in the Molecular Machinery of the Clock: Its Effect on Thrombogenesis and Fibrinolysis Through PAI-1 {#S3.SS1}
----------------------------------------------------------------------------------------------------------------

As described above, the fibrinolytic system is an important endogenous defense system against intravascular thrombosis. The evidence indicates that its main modulator is the PAI-1 inhibitor, which is currently classified as an independent risk factor for CVD ([@B71]; [@B29]). On the other hand, the circadian expression of PAI-1 is regulated by the molecular machinery of peripheral clocks; various clock genes determine both their level of expression and circadian rhythmicity. This suggests that an alteration in the expression of the clock genes, by means of genetic ablations DNA mutations or by circadian disruption by alterations of the dark/light cycles, could promote a decrease in fibrinolytic activity or hypofibrinolysis, thereby increasing the predisposition to the development of CVD.

In recent years, it has been reported that disruption models of the *Bmal1* clock gene in mice develop various characteristics that combined describe a prothrombotic phenotype. One study that used mice deficient in *Bmal1* (*Bmal1*^--/--^) showed significant differences from the control group: shorter times of cessation of tail bleeding, significantly shorter arterial occlusion times after an injury, increased plasma fibrinogen levels and a significant increase in plasma levels, and an absence of a circadian pattern for PAI-1 ([@B65]). Other models have confirmed the progression of a prothrombotic state in knockout mice (KO) for *Bmal1* during the development of aging: The results showed shorter prothrombin times, increased platelet count, decreased endothelial production of nitric oxide and thrombomodulin expression ([@B25]), confirming a close functional relationship between the central loop of the clock and the regulation of the hemostasis. Later studies also showed that *Bmal1* deficiencies (*Bmal1*^--/--^ mice) clearly disrupt the daily rhythm in the expression of relevant coagulation and fibrinolysis factors. Specifically in the liver, an increase in the gene expression of *fibrinogen*, *tissue factor*, *protein C*, and *Pai-1* have been observed while *tPA* is decreased; however, plasma levels of PAI-1 are reduced, which disagrees with reports by Somanath et al., where they were found to be increased. This discrepancy may be related to differences in the light/dark protocols in which the mice were kept ([@B65]; [@B24]).

The effects found in the liver are interesting because this organ is the most important in the synthesis of coagulation and fibrinolysis factors ([@B14]; [@B30]). Furthermore, it has often been described as an important peripheral circadian clock ([@B54]; [@B68]; [@B79]); therefore, any desynchronization or disruption of its circadian rhythm could have side effects on the physiological functions it performs.

On the other hand, CLOCK is also important for maintaining the diurnal variation of thrombogenesis. The mutation of CLOCK in mice (CLOCK^mut^) alters the fibrinolytic system; total and active plasma levels of PAI-1 are elevated and tPA is reduced. In addition, these effects would be related to the small but significant increase in vascular occlusion time observed in this experimental model ([@B77]). Interestingly, in patients with acute coronary syndrome, CLOCK and PAI-1 were overexpressed in peripheral blood macrophage cells, suggesting that CLOCK might play an important role in the progression of atherosclerotic plaques ([@B28]). Taken together, these results show that clock genes control the expression of key components in hemostatic function and the fibrinolysis system, which leads to an increased risk of developing a prothrombotic phenotype and thus an increased risk of harmful cardiovascular events.

Update on Unusual Exposure to Artificial Light and Its Impact on Fibrinolytic Activity {#S3.SS2}
--------------------------------------------------------------------------------------

A reduced fibrinolytic activity due to an increase in the expression of PAI-1 is a characteristic risk factor for CVD due to its role in vascular homeostasis ([@B36]; [@B45]). In addition, as described above, its plasma levels have a typical circadian rhythm and its gene expression is regulated by clock genes; therefore, PAI-1 is a component capable of being disturbed through a circadian disruption. It is known that the light is a dominant stimulus for training circadian rhythms in mammals, and exposure to light at inappropriate times such as during the resting stage could alter the physiology of tissues, organs and systems ([@B56]; [@B52]), including the fibrinolytic system. To date, the studies that are known have examined the experimental effect of a chronic alteration of the photoperiod on the expression of PAI-1. For this, mouse models have been used (rodents and humans have the same circadian profile for PAI-1 and tPA in the rest/activity cycle), exposed to a temporary desynchronization of the endogenous circadian clock, imitating the working schemes of rotating shifts. The results show that the hepatic expression of *Pai-1* and its plasma levels increase significantly while the *tPA* expression decreases. Additionally, increased levels of plasma corticosterone were found, suggesting a relationship between the hypothalamic--pituitary--adrenal axis and the expression of *Pai-1* ([@B47]). In another study, alterations in the hepatic expression of clock genes such as *Clock*, *Bmal1*, and *Per1* were found in mice exposed to artificial light pulses during the night phase, and in the same way, an increase in both transcriptional hepatic expression and plasma protein of PAI-1 was observed ([@B4]). In humans, it seems that the indispensable requirement for an increase in PAI-1 levels is a chronic circadian desynchronization because short-term circadian misalignment lowers the 24-h PAI-1 levels ([@B42]).

Conclusion {#S4}
==========

The evidence suggests that a disturbance of the endogenous circadian rhythm mediated by the photoperiod alteration induces a state of hypofibrinolysis, mainly by promoting an alteration in the expression of PAI-1 and tPA, due to its direct regulation by the circadian synchronization system. Additional studies on animal models and humans are needed to determine the association of these findings on the origin and/or development of CVD and other chronic diseases in which PAI-1 and tPA are involved in their pathophysiology, in order to prevent the appearance of chronic diseases in adulthood due to exposure to chronodisruption.
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